Status: Not yet recruiting
Tornier Perform™ Reversed Monopost Study
This study is a Multi-center, Prospective Follow-up, Non-significant risk, Post-Market Clinical Follow-Up (PMCF) study to Evaluate the Safety and Effectiveness of the Tornier Perform™ Reversed MonoPost System.
Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Stryker Trauma and ExtremitiesUpdated: Aug 21, 2026
Eligibility criteria
18 years or older at the time of the informed consent. [+9]
Contraindications or hypersensitivity to the use of the Tornier Perform™ Reverse... [+2]